Press Releases
Philogen provides Corporate Update
Philogen to hold a Webinar at 11 am EST / 4 pm GMT / 5 pm CET on Friday 12th November 2021, Click here to view
Upcoming Events
Philogen to attend the Cytokine-Based Cancer Immunotherapies Summit on November 30-December 2 , 2021
Dario Neri, co-founder, CEO and CSO, is giving a presentation to address the question on how to achieve the therapeutic dose at the tumor site with cytokine-based targeted products. Roberto...
Read morePhilogen to attend the Antibody Engineering & Therapeutics on December 12-16 , 2021
Dario Neri, co-founder, CEO and CSO, is giving a presentation focused on Tripokin, a novel fusion protein capable of an exceptionally selective uptake at the tumor site. The product contains...
Read morePast Events
Philogen together with the University of Zürich to participate at the 26th Annual Meeting & Education of the Society for Neuro-Oncology on November 18-21, 2021
Dr. Tobias Weiss, the Principal Investigator of Fibromun’s programs in brain tumors, is presenting an ePoster entitled “Lomustine and targeted-cytokine therapy: a beneficial liaison for recurrent glioblastoma
Philogen to attend the Connective Tissue Oncology Society (CTOS) Virtual 2021 Annual Meeting on November 10-13, 2021
Philogen is presenting a ePoster on the results of the run-in part of the Phase II study with Fibromun plus Dacarbazine for patients with in third or later line advanced/metastatic...
Read more